Table 4 Atlantic salmon derived bioactive peptides

GPAV

415.91 ± 2.65 (µM)

245.58 ± 7.15 (µM)

9.51 ± 1.40

Neves et al. (2017a)

VP

1215.15 ± 83.14 (µM)

758.15 ± 12.45 (µM)

19.45 ± 2.15

VC

134.45 ± 5.15 (µM)

5413.45 ± 62.15 (µM)

3.45 ± 0.78

YP

5.21 ± 0.94 (µM)

7564.02 ± 42.45 (µM)

17.18 ± 1.54

FF

59.15 ± 0.54 (µM)

546.84 ± 8.15 (µM)

8.47 ± 1.05

PP

1912.46 ± 63.15 (µM)

4343.48 ± 29.78 (µM)

12.48 ± 1.47

W

135.48 ± 5.48 (µM)

438.15 ± 10.97 (µM)

4.31 ± 0.19

F

125.15 ± 2.64 (µM)

295.15 ± 6.45 (µM)

4.59 ± 0.89

Y

182.84 ± 0.52 (µM)

75.15 ± 0.84 (µM)

2.74 ± 0.65

GF

178.14 ± 24.51 (µM)

1547.15 ± 34.15 (µM)

19.74 ± 1.01

Neves et al. (2017b)

GPVA

445.61 ± 6.94 (µM)

264.74 ± 1.59 (µM)

9.48 ± 0.94

GGPAGPAV

673.16 ± 15.03 (µM)

8139.11 ± 134.68 (µM)

5.47 ± 0.94

R

98.04 ± 0.15 (µM)

110.44 ± 0.47 (µM)

4.71 ± 0.09

PAY

0.75

Ahn et al. (2015)

VWDPPKFD

9.12 ± 1.07 (µM)

FEDYVPLSCF

13.72 ± 2.54 (µM)

FNVPLYE

6.79 ± 0.78 (µM)

AP

0.060 ± 0.001 mg/mL

Gu et al. (2011)

VR

0.332 ± 0.005 mg/mL

GAAGR

AGPS

VDGK

RER

LN

VTGK

GHAGE

VGGK

GHGR

GAPE

49.6 (µM)

Li-Chan et al. (2012)

GPGA

41.9 (µM)

YYGYTGAFR

1.21 mg/mL

Jin et al. (2020)

LDKVFR

0.10 mg/mL

VLATSGPG

0.18 mg/mL

PR

91.3

Wang et al. (2008)

IVY

0.48 (µM)

Darewicz et al. (2014)

VW

1.4 (µM)

IY

2.1 (µM)

IW

4.7 (µM)

VY

7.1 (µM)

TVY

15 (µM)

VFPS

0.46 (µM)

VTVNPYKWLP

5.5 (µM)

IWHHT

5.8 (µM)

YALPHA

9.8 (µM)

ALPHA

10 (µM)